ARUP is accepting new COVID-19 molecular test orders from clients with prior authorization. For more information about the authorization process, please contact Client Services at (800) 522-2787.

Read more here about ARUP’s response to COVID-19.

Ordering Recommendation

Use to detect the 2019 novel coronavirus (SARS-CoV-2).

Mnemonic
COVID19NAA
Methodology

Qualitative Nucleic Acid Amplification

Performed

Daily

Reported

1-4 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Nasopharyngeal swab.
Also acceptable:
Oropharyngeal or Nasal swab.
Refer to the "COVID-19 Specimen Collection Guide" at https://www.aruplab.com/infectious-disease/coronavirus/testing

Specimen Preparation

Nasopharyngeal swab: Place in viral transport media, Liquid Amies, or saline (minimum volume 1.2mL). Place each specimen in an individually sealed bag.
Oropharyngeal or nasal swab: Place in viral transport media, Liquid Amies, or saline (minimum volume 1.2mL). Or collect using the Aptima Multitest Swab Collection Kit. Place each specimen in an individually sealed bag.
Also acceptable: Media that is equivalent to viral transport media or universal transport media.

Storage/Transport Temperature

Frozen

Unacceptable Conditions

Wood swabs, calcium alginate swabs.

Remarks

Specimen source required.

Stability

Ambient: Unacceptable; Refrigerated: 2 days; Frozen: 1 month

Reference Interval
Interpretive Data

This test should be ordered for the detection of the 2019 novel coronavirus SARS-CoV-2 in individuals who meet SARS-CoV-2 clinical and/or epidemiological criteria.

The Coronavirus SARS-CoV-2 (COVID-19) by nucleic acid amplification test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for US laboratories certified under CLIA to perform high complexity tests. This test has not been FDA cleared or approved. In compliance with this authorization, please visit https://www.aruplab.com/infectious-disease/coronavirus for more information and to access the applicable information sheets.

If the result is Not Detected, this does not rule out the presence of PCR inhibitors in the patient specimen or assay specific nucleic acid in concentrations below the level of detection by the assay.

No compliance statements are in use for this test.

Note
Hotline History
N/A
CPT Codes

U0003; (Alt code: 87635)

Components
Component Test Code* Component Chart Name LOINC
3002639 SARS-CoV-2 Source 31208-2
3002640 SARS-CoV-2 by NAA 94500-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • 2019-nCoV
  • Coronavirus disease - 2019
  • COVID-19
  • COVID-19 Illness
  • COVID-2019
  • SARS-CoV-2
  • Wuhan
SARS-CoV-2 (COVID-19) by NAA